NeOnc Technologies Holdings, Inc. Common Stock (NTHI)

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $79.2M; returns 1 day +10.8%, 1 week +21.1%, 1 year -60.8%.

NeOnc Technologies Holdings, Inc. (NTHI) is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system (CNS) diseases, particularly intracranial malignancies like brain cancer. The company's primary product candidates are NEO100 and NEO212.

Groups NTHI belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• CNS Disorders
• Biopharmaceutical
• Healthcare
• Life Sciences
• Cancer Therapeutics
• Fast Track Designation
• Clinical Stage
• Drug Discovery

NTHI financial model: income statement, cash flow and balance sheet